Abstract:Glenn T Werneburg Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA Correspondence: Glenn T Werneburg, Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA, Tel +1 216-444-2200, Email Catheter-associated urinary tract infection (CAUTI) is the most common healthcare-associated infection and cause of secondary bloodstream infections. Despite many advances in diagnosis, prevention and treatment, CAUTI remains a severe healthcare burden, and antibiotic resistance rates are alarmingly high. In this review, current CAUTI management paradigms and challenges are discussed, followed by future prospects as they relate to the diagnosis, prevention, and treatment. Clinical and translational evidence will be evaluated, as will key basic science studies that underlie preventive and therapeutic approaches. Novel diagnostic strategies and treatment decision aids under development will decrease the time to diagnosis and improve antibiotic accuracy and stewardship. These include several classes of biomarkers often coupled with artificial intelligence algorithms, cell-free DNA, and others. New preventive strategies including catheter coatings and materials, vaccination, and bacterial interference are being developed and investigated. The antibiotic pipeline remains insufficient, and new strategies for the identification of new classes of antibiotics, and rational design of small molecule inhibitor alternatives, are under development for CAUTI treatment. Keywords: catheter-associated urinary tract infection, biofilm, bacterial interference, bacterial competition, chaperone-usher, machine learning Urinary tract infections (UTI) are among the most common bacterial infections, and affect about 150 million individuals annually worldwide. 1 UTIs are grouped into uncomplicated and complicated infections. 2 Uncomplicated UTIs occur in female individuals who are not immunocompromised, have no foreign bodies in the urinary tract and have not undergone urinary tract manipulation recently, and have no anatomical or neurologic abnormalities in the urinary tract. Complicated UTIs occur in the context of a structural or functional abnormality. Examples include patients with urinary tract obstruction or urinary retention (due to neurological disease, for example), immunocompromised state, pregnancy, or those with an indwelling foreign body such as a stone, ureteral stent, or urinary catheter. 3,4 UTIs in men are considered complicated regardless of clinical scenario. In the United States, up to 80% of complicated urinary tract infection are attributable to indwelling urinary catheters. 5 These infections are termed catheter-associated urinary tract infections and are the focus of this review. Catheter-associated urinary tract infections (CAUTI) are urinary tract infections occurring in an individual whose urinary bladder is catheterized or has been catheterized within the past 48 hours. CAUTIs are the most common nosocomial infections, and account for 1 million cases per year in the United States. 6 They are the most common cause of secondary bloodstream infections. 3–10% of residents in long-term care facilities are managed with chronic indwelling catheters. 7,8 The associated costs of preventable CAUTI are estimated to range from 1.82 billion annually. 9 Risk factors for CAUTI include age, female gender, diabetes, and prolonged catheterization time. 10 The duration of catheterization is the most important factor in the development of bacteriuria, with a risk of 3–7% daily. 8 A mean of 3.2 urinary tract infections per 1000 catheter days was reported in long-term care facilities in a US study 11 In the intensive care unit (ICU), where infection rates are 3–5 times higher than other hospital patient care areas, the incidence of CAUTI is 7.78 per 1000 catheter days. 12 CAUTIs in ICUs are associated with increased lengths of stay, higher health-care financial expenditure, and antibiotic overuse. 13,14 UTIs may be caused by both Gram-negative and Gram-positive bacteria, as well as fungi. Uropathogenic Escherichia coli (UPEC) is the most common pathogen for both non-complicated and complicated UTI, making up 75% and 65% of infections, respectively. 2 In complicated UTI, wherein CAUTIs make of the majority of cases, the overall most common causative organisms after UPEC include Enterococcus spp. (11%), Klebsiella pneumoniae (8%), Candida spp (7%), Staphylococcus aureus (3%), Proteus mirabilis (2%), Pseudomonas aeruginosa (2%), and Group B Streptococcus (2%). The cornerstone for CAUTI is antibiotics. How -Abstract Truncated-

Urinary Catheter-Associated Infections

Diagnosis, Management, and Prevention of Catheter-Associated Urinary Tract Infections

Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals

Catheter-associated urinary tract infection: an overview

Reducing unnecessary urinary catheter use and other strategies to prevent catheter-associated urinary tract infection: an integrative review

Reduction of Catheter-Associated Urinary Tract Infections

Nurse-directed interventions to reduce catheter-associated urinary tract infections

Estimating hospital costs of catheter-associated urinary tract infection

An Eye on CAUTI Prevention: Bridging the Gap in the Prevention of Catheter-Associated Urinary Tract Infections

Catheter-Associated Urinary Tract Infections: Current Challenges and Future Prospects

Identifying the risk factors for catheter-associated urinary tract infections: a large cross-sectional study of six hospitals

Reduction of Catheter-Associated Urinary Tract Infections: A Multidisciplinary Approach to Driving Change

Materials-based incidence of urinary catheter associated urinary tract infections and the causative micro-organisms: systematic review and meta-analysis

Reducing catheter-associated urinary tract infections in the ICU

Urinary-catheter-associated infections in the elderly

New strategies to prevent catheter-associated urinary tract infections

A multifaceted quality improvement strategy reduces the risk of catheter-associated urinary tract infection

Prevention and Treatment of Urinary Catheter-Related Infections in Older Patients

An Observational Study from Northern India to Evaluate Catheter-associated Urinary Tract Infection in Medical Intensive Care Unit at a Tertiary Care Center

1152. Implementation of Enhanced Data Surveillance Methods to Reduce Catheter-Associated Urinary Tract Infections

Incidence and risk factors for catheter-associated urinary tract infection in 623 intensive care units throughout 37 Asian, African, Eastern European, Latin American, and Middle Eastern nations: A multinational prospective research of INICC